| First Author | Wu Z | Year | 2014 |
| Journal | Matrix Biol | Volume | 35 |
| Pages | 266-75 | PubMed ID | 24373743 |
| Mgi Jnum | J:215417 | Mgi Id | MGI:5605240 |
| Doi | 10.1016/j.matbio.2013.12.006 | Citation | Wu Z, et al. (2014) Biglycan and decorin differentially regulate signaling in the fetal membranes. Matrix Biol 35:266-75 |
| abstractText | Preterm birth is the leading cause of newborn mortality in the United States and about one third of cases are caused by preterm premature rupture of fetal membranes, a complication that is frequently observed in patients with Ehlers-Danlos Syndrome. Notably, a subtype of Ehlers-Danlos Syndrome is caused by expression of abnormal biglycan and decorin proteoglycans. As compound deficiency of these two small leucine-rich proteoglycans is a model of preterm birth, we investigated the fetal membranes of Bgn(-/-); Dcn(-/-) double-null and single-null mice. Our results showed that biglycan signaling supported fetal membrane remodeling during early gestation in the absence of concomitant changes in TGFbeta levels. In late gestation, biglycan signaling acted in a TGFbeta-dependent manner to aid in membrane stabilization. In contrast, decorin signaling supported fetal membrane remodeling at early stages of gestation in a TGFbeta-dependent manner, and fetal membrane stabilization at later stages of gestation without changes in TGFbeta levels. Furthermore, exogenous soluble decorin was capable of rescuing the TGFbeta signaling pathway in fetal membrane mesenchymal cells. Collectively, these findings provide novel targets for manipulation of fetal membrane extracellular matrix stability and could represent novel targets for research on preventive strategies for preterm premature rupture of fetal membranes. |
